Shares of WellCare Health Plans Inc. (NYSE:WCG) reached a new 52-week high during mid-day trading on Monday . The company traded as high as $114.26 and last traded at $114.15, with a volume of 249,995 shares trading hands. The stock had previously closed at $113.33.

A number of analysts recently issued reports on WCG shares. Credit Suisse Group AG reiterated a “sell” rating and set a $100.00 price objective on shares of WellCare Health Plans in a research note on Wednesday, August 3rd. Morgan Stanley reiterated a “sell” rating and set a $80.00 price objective on shares of WellCare Health Plans in a research note on Wednesday, August 3rd. JPMorgan Chase & Co. reiterated a “buy” rating and set a $115.00 price objective on shares of WellCare Health Plans in a research note on Wednesday, August 3rd. Wedbush restated a “neutral” rating and set a $108.00 target price on shares of WellCare Health Plans in a research report on Monday, June 20th. Finally, Jefferies Group boosted their target price on WellCare Health Plans to $105.00 in a research report on Wednesday, August 3rd. Two research analysts have rated the stock with a sell rating, five have given a hold rating and five have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $99.82.

The firm’s 50 day moving average is $107.53 and its 200 day moving average is $94.81. The company has a market capitalization of $5.03 billion and a P/E ratio of 28.40.

WellCare Health Plans (NYSE:WCG) last announced its earnings results on Tuesday, August 2nd. The company reported $2.23 EPS for the quarter, topping the Zacks’ consensus estimate of $1.40 by $0.83. The company earned $3.59 billion during the quarter, compared to the consensus estimate of $3.53 billion. WellCare Health Plans’s revenue for the quarter was up 3.2% compared to the same quarter last year. During the same period in the prior year, the business posted $1.34 earnings per share. On average, equities analysts predict that WellCare Health Plans Inc. will post $5.04 earnings per share for the current fiscal year.

In related news, Director Kevin F. Hickey sold 1,000 shares of the firm’s stock in a transaction on Wednesday, June 15th. The stock was sold at an average price of $105.56, for a total value of $105,560.00. Following the transaction, the director now directly owns 14,730 shares of the company’s stock, valued at approximately $1,554,898.80. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

A number of institutional investors recently made changes to their positions in the company. Matarin Capital Management LLC bought a new position in shares of WellCare Health Plans during the fourth quarter worth approximately $5,107,000. Systematic Financial Management LP boosted its stake in WellCare Health Plans by 16.8% in the fourth quarter. Systematic Financial Management LP now owns 225,058 shares of the company’s stock worth $17,601,000 after buying an additional 32,422 shares in the last quarter. BlackRock Advisors LLC boosted its stake in WellCare Health Plans by 11.6% in the fourth quarter. BlackRock Advisors LLC now owns 204,658 shares of the company’s stock worth $16,007,000 after buying an additional 21,296 shares in the last quarter. New York State Common Retirement Fund boosted its stake in WellCare Health Plans by 10.8% in the fourth quarter. New York State Common Retirement Fund now owns 159,923 shares of the company’s stock worth $12,508,000 after buying an additional 15,640 shares in the last quarter. Finally, Bank of Montreal Can boosted its stake in WellCare Health Plans by 4.9% in the fourth quarter. Bank of Montreal Can now owns 147,627 shares of the company’s stock worth $11,546,000 after buying an additional 6,834 shares in the last quarter.

WellCare Health Plans, Inc (WellCare) is a managed care company for government-sponsored health care coverage with a focus on Medicaid and Medicare programs. The Company offers a range of managed care health plans for families, children, and the aged, blind and disabled, as well as prescription drug plans.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.